Back to Trades
McKechnie Duncan
EVP, Chief Commercial OfficerCIK: 0002062139
McKechnie Duncan, EVP, Chief Commercial Officer, has filed 3 insider trading reports covering 1 company. Total disclosed trading volume is $3.9M. Sales ($2.4M) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves VERTEX PHARMACEUTICALS INC / MA (VRTX). All transactions sourced from SEC Form 4 filings.
Total Volume
$3.9M
Purchases
$0
Sales
$2.4M
Companies
1
Trading History (3 filings)
McKechnie DuncanEVP, Chief Commercial Officer
Filed Feb 26, 2026
Sell
$2.4M
2 sales
McKechnie DuncanEVP, Chief Commercial Officer
Filed Feb 19, 2026
Grant
$0
1 grant
McKechnie DuncanEVP, Chief Commercial Officer
Filed Feb 12, 2026
Other
$0